Allergan Asks Fed. Circ. For Block On Generic Zymaxid
Allergan Inc. and two other pharmaceutical companies asked the Federal Circuit on Tuesday to issue an injunction to prevent rivals Lupin Ltd. and Hi-Tech Pharmacal Co. Inc. from marketing a generic version...To view the full article, register now.
Already a subscriber? Click here to view full article